| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
5 companies
Third Rock Ventures Iv, L.P. is a 10% Owner at Tango Therapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $908.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 477,401 | $10.15 | $4,846,574.95 | -3.4% | +66.1% | - | |
| Sep 25, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 500,000 | $8.02 | $4,008,500.00 | -3.5% | +9.2% | - | |
| Sep 16, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 363,541 | $7.04 | $2,559,328.64 | -2.5% | +24.1% | - | |
| Sep 8, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 729,365 | $7.00 | $5,108,970.13 | -2.4% | +41.0% | - | |
| Aug 22, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 302,194 | $7.00 | $2,115,358.00 | -1.9% | +29.0% | - | |
| Aug 19, 2025 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 1,100,000 | $7.01 | $7,712,760.00 | -6.5% | +14.7% | - | |
| Sep 13, 2024 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 67,400 | $10.53 | $709,755.70 | -0.4% | -72.9% | -37.8% | |
| Sep 5, 2024 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 75,000 | $11.56 | $867,135.00 | -0.4% | -69.9% | -40.6% | |
| Aug 30, 2024 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 175,000 | $11.60 | $2,029,702.50 | -1.0% | -66.7% | -43.3% | |
| Aug 27, 2024 | TNGX Tango Therapeutics, Inc. | 10% Owner | Sell | 25,000 | $11.55 | $288,665.00 | -0.1% | -66.7% | -39.5% |